Long-defined by high prices, shortages and weekly injections, weight loss drugs including Wegovy and Zepbound are expected to ...
Reduced mobility raises the risk of obesity, while weakness and poor balance markedly increase the chance of a potentially ...
HotCopper on MSN
Paradigm Biopharma rolls into CY26 on patient tailwinds after hitting 25% recruitment milestone
Late-stage drug developer Paradigm Biopharmaceuticals (ASX:PAR) is preparing for a huge CY26 after landing a key recruitment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback